Draft Guidance for Industry and Staff; Availability: Procedures for Handling Section 522 Postmarket Surveillance Studies
Title: RTI Biologics Inc Comment
RTI Biologics, Inc. - Comment
This is comment on Notice
Draft Guidance for Industry and Staff; Availability: Procedures for Handling Section 522 Postmarket Surveillance Studies
View Comment
Attachments:
RTI Biologics Inc Comment
Title:
RTI Biologics Inc Comment
Related Comments
View AllPublic Submission Posted: 11/16/2011 ID: FDA-2011-D-0514-0003
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0004
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0005
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0007
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/09/2011 ID: FDA-2011-D-0514-0008
Nov 14,2011 11:59 PM ET